Brian Lee Baker, SVP of Finance and Administration at Turning Point Therapeutics, Inc. (TPTX), sold 56,770 shares at $100.98 ($5.7M) on 2021-03-23, disclosed to the SEC on 2021-03-24.
Open-market sale of $5.7M TPTX by SVP of Finance and Administration. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.89 | 4,919 | $482K | 8.4% |
| 2 | $97.89 | 4,919 | $482K | 8.4% |
| 3 | $98.76 | 4,459 | $440K | 7.7% |
| 4 | $98.76 | 4,459 | $440K | 7.7% |
| 5 | $100.07 | 1,996 | $200K | 3.5% |
| 6 | $100.07 | 1,996 |
| $200K |
| 3.5% |
| 7 | $100.98 | 5,010 | $506K | 8.9% |
| 8 | $100.98 | 5,010 | $506K | 8.9% |
| 9 | $102.23 | 8,061 | $824K | 14.4% |
| 10 | $102.23 | 8,061 | $824K | 14.4% |
| 11 | $102.84 | 3,890 | $400K | 7.0% |
| 12 | $102.84 | 3,890 | $400K | 7.0% |
| 13 | $104.17 | 100 | $10K | 0.2% |
| Total | $100.65 avg | 56,770 | $5.7M | 100% |
| Filing → |